Schrödinger (SDGR) Stock Forecast, Price Target & Predictions
SDGR Stock Forecast
Schrödinger stock forecast is as follows: an average price target of $28.67 (represents a 57.18% upside from SDGR’s last price of $18.24) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
SDGR Price Target
SDGR Analyst Ratings
Schrödinger Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 23, 2024 | Chris Shibutani | Goldman Sachs | $27.00 | $19.60 | 37.76% | 48.03% |
Aug 21, 2024 | Vikram Purohit | Morgan Stanley | $30.00 | $20.44 | 46.74% | 64.47% |
Jul 02, 2024 | Mani Foroohar | Leerink Partners | $29.00 | $18.76 | 54.58% | 58.99% |
Dec 19, 2022 | Chris Shibutani | Goldman Sachs | $23.00 | $20.54 | 11.98% | 26.10% |
Schrödinger Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 2 | 3 |
Avg Price Target | - | $28.50 | $28.67 |
Last Closing Price | $18.24 | $18.24 | $18.24 |
Upside/Downside | -100.00% | 56.25% | 57.18% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 17, 2024 | BMO Capital | Outperform | Outperform | Hold |
Sep 23, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Sep 13, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 21, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Jul 11, 2024 | KeyBanc | Overweight | Overweight | Hold |
May 02, 2024 | Craig-Hallum | Buy | Buy | Hold |
May 02, 2024 | Citigroup | Buy | Buy | Hold |
Jun 29, 2023 | Morgan Stanley | Underweight | Underweight | Hold |
Jan 31, 2023 | Citigroup | Buy | Buy | Hold |
Dec 19, 2022 | Goldman Sachs | - | Neutral | Initialise |
Schrödinger Financial Forecast
Schrödinger Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $42.57M | $35.19M | $64.78M | $56.84M | $36.98M | $38.47M | $48.66M | $46.17M | $29.85M | $29.78M | $32.13M | $33.03M | $25.80M | $23.09M | $26.17M |
Avg Forecast | $99.79M | $48.37M | $51.58M | $46.22M | $85.32M | $40.61M | $39.61M | $41.96M | $79.12M | $37.85M | $38.27M | $64.95M | $47.44M | $30.84M | $35.48M | $34.57M | $36.80M | $31.58M | $29.88M | $29.23M | $37.87M | $23.03M | $17.93M | $22.21M |
High Forecast | $99.79M | $48.37M | $51.58M | $46.22M | $85.32M | $45.33M | $39.61M | $41.96M | $81.56M | $37.85M | $38.27M | $64.95M | $47.44M | $30.84M | $35.48M | $34.57M | $36.80M | $31.58M | $29.88M | $29.23M | $37.87M | $23.03M | $17.93M | $22.21M |
Low Forecast | $99.79M | $48.37M | $51.58M | $46.22M | $85.32M | $35.19M | $39.61M | $41.96M | $76.27M | $37.85M | $38.27M | $64.95M | $47.44M | $30.84M | $35.48M | $34.57M | $36.80M | $31.58M | $29.88M | $29.23M | $37.87M | $23.03M | $17.93M | $22.21M |
# Analysts | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.12% | 0.92% | 1.00% | 1.20% | 1.20% | 1.08% | 1.41% | 1.25% | 0.95% | 1.00% | 1.10% | 0.87% | 1.12% | 1.29% | 1.18% |
Schrödinger EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | $-56.19M | $-61.13M | $-64.48M | $-25.90M | $-50.33M | $-26.65M | $-21.51M | $-29.79M | $-34.14M | $-33.49M | $1.35M | $-9.38M | $5.17M | $-1.83M | $-12.16M |
Avg Forecast | $-75.45M | $-36.57M | $-39.00M | $-34.94M | $-64.50M | $-30.70M | $-29.95M | $-44.91M | $-59.82M | $-28.62M | $-28.93M | $-40.83M | $-29.41M | $-23.32M | $-26.82M | $-37.12M | $-27.82M | $-23.88M | $-22.59M | $2.43M | $-28.63M | $-17.41M | $-13.56M | $-6.08M |
High Forecast | $-75.45M | $-36.57M | $-39.00M | $-34.94M | $-64.50M | $-26.61M | $-29.95M | $-35.93M | $-57.66M | $-28.62M | $-28.93M | $-32.66M | $-23.53M | $-23.32M | $-26.82M | $-29.69M | $-27.82M | $-23.88M | $-22.59M | $2.92M | $-28.63M | $-17.41M | $-13.56M | $-4.86M |
Low Forecast | $-75.45M | $-36.57M | $-39.00M | $-34.94M | $-64.50M | $-34.27M | $-29.95M | $-53.90M | $-61.66M | $-28.62M | $-28.93M | $-49.00M | $-35.29M | $-23.32M | $-26.82M | $-44.54M | $-27.82M | $-23.88M | $-22.59M | $1.94M | $-28.63M | $-17.41M | $-13.56M | $-7.30M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.96% | 2.11% | 1.58% | 0.88% | 2.16% | 0.99% | 0.58% | 1.07% | 1.43% | 1.48% | 0.56% | 0.33% | -0.30% | 0.14% | 2.00% |
Schrödinger Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | $-62.02M | $4.28M | $129.14M | $-27.21M | $-39.86M | $-47.67M | $-34.45M | $-30.71M | $-35.01M | $-34.64M | $-29.00K | $-11.14M | $3.85M | $-3.35M | $-13.83M |
Avg Forecast | $-21.57M | $-63.74M | $-58.90M | $-59.87M | $-24.71M | $-43.33M | $-60.50M | $-44.88M | $-29.09M | $-49.97M | $-36.93M | $-40.80M | $-30.32M | $-45.91M | $-39.47M | $-37.09M | $-23.99M | $-27.19M | $-19.49M | $-52.13K | $-5.45M | $-4.18M | $-20.18M | $-6.91M |
High Forecast | $-21.57M | $-63.74M | $-58.90M | $-59.87M | $-24.71M | $-6.50M | $-60.50M | $-35.90M | $-25.79M | $-49.97M | $-36.93M | $-32.64M | $-24.26M | $-45.91M | $-39.47M | $-29.67M | $-23.99M | $-27.19M | $-19.49M | $-41.70K | $-5.45M | $-4.18M | $-20.18M | $-5.53M |
Low Forecast | $-21.57M | $-63.74M | $-58.90M | $-59.87M | $-24.71M | $-79.08M | $-60.50M | $-53.85M | $-33.06M | $-49.97M | $-36.93M | $-48.96M | $-36.38M | $-45.91M | $-39.47M | $-44.51M | $-23.99M | $-27.19M | $-19.49M | $-62.56K | $-5.45M | $-4.18M | $-20.18M | $-8.30M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.24% | -0.12% | -3.17% | 0.90% | 0.87% | 1.21% | 0.93% | 1.28% | 1.29% | 1.78% | 0.56% | 2.04% | -0.92% | 0.17% | 2.00% |
Schrödinger SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | $33.00M | $32.24M | $35.45M | $32.70M | $30.48M | $29.48M | $28.80M | $23.73M | $22.57M | $21.23M | $18.63M | $18.26M | $13.70M | $14.01M | $13.72M |
Avg Forecast | $60.69M | $29.41M | $31.37M | $28.11M | $51.88M | $24.69M | $24.09M | $37.53M | $48.11M | $23.02M | $23.27M | $34.12M | $23.43M | $18.76M | $21.57M | $31.02M | $22.38M | $19.21M | $18.17M | $17.78M | $23.03M | $14.01M | $10.90M | $6.86M |
High Forecast | $60.69M | $29.41M | $31.37M | $28.11M | $51.88M | $27.56M | $24.09M | $45.04M | $49.60M | $23.02M | $23.27M | $40.95M | $28.11M | $18.76M | $21.57M | $37.22M | $22.38M | $19.21M | $18.17M | $17.78M | $23.03M | $14.01M | $10.90M | $8.23M |
Low Forecast | $60.69M | $29.41M | $31.37M | $28.11M | $51.88M | $21.40M | $24.09M | $30.03M | $46.38M | $23.02M | $23.27M | $27.30M | $18.74M | $18.76M | $21.57M | $24.82M | $22.38M | $19.21M | $18.17M | $17.78M | $23.03M | $14.01M | $10.90M | $5.49M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.43% | 1.39% | 1.04% | 1.40% | 1.62% | 1.37% | 0.93% | 1.06% | 1.18% | 1.17% | 1.05% | 0.79% | 0.98% | 1.29% | 2.00% |
Schrödinger EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 5 | 2 | 2 | 3 | 7 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | - | $-0.86 | $0.06 | $1.81 | $-0.38 | $-0.56 | $-0.67 | $-0.48 | $-0.43 | $-0.49 | $-0.49 | $-0.00 | $-0.17 | $0.06 | $-0.05 | $-0.34 |
Avg Forecast | $-0.30 | $-0.88 | $-0.81 | $-0.82 | $-0.34 | $-0.60 | $-0.83 | $-0.74 | $-0.40 | $-0.69 | $-0.51 | $1.28 | $-0.50 | $-0.63 | $-0.54 | $-0.47 | $-0.33 | $-0.37 | $-0.27 | $-0.15 | $-0.07 | $-0.06 | $-0.28 | $-0.23 |
High Forecast | $-0.30 | $-0.88 | $-0.81 | $-0.82 | $-0.34 | $-0.09 | $-0.83 | $-0.74 | $-0.35 | $-0.69 | $-0.51 | $1.28 | $-0.50 | $-0.63 | $-0.54 | $-0.47 | $-0.33 | $-0.37 | $-0.27 | $-0.15 | $-0.07 | $-0.06 | $-0.28 | $-0.23 |
Low Forecast | $-0.30 | $-0.88 | $-0.81 | $-0.82 | $-0.34 | $-1.09 | $-0.83 | $-0.74 | $-0.45 | $-0.69 | $-0.51 | $1.28 | $-0.50 | $-0.63 | $-0.54 | $-0.47 | $-0.33 | $-0.37 | $-0.27 | $-0.15 | $-0.07 | $-0.06 | $-0.28 | $-0.23 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.25% | -0.12% | 1.41% | 0.76% | 0.89% | 1.23% | 1.03% | 1.30% | 1.31% | 1.83% | 0.00% | 2.24% | -1.04% | 0.18% | 1.49% |
Schrödinger Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TDOC | Teladoc Health | $8.87 | $50.87 | 473.51% | Hold |
ACCD | Accolade | $3.15 | $14.81 | 370.16% | Buy |
CERT | Certara | $10.25 | $20.60 | 100.98% | Buy |
PGNY | Progyny | $15.15 | $29.00 | 91.42% | Hold |
TXG | 10x Genomics | $16.78 | $30.20 | 79.98% | Hold |
SDGR | Schrödinger | $18.24 | $28.67 | 57.18% | Buy |
HQY | HealthEquity | $86.95 | $97.00 | 11.56% | Buy |
VEEV | Veeva Systems | $212.53 | $229.71 | 8.08% | Buy |
GEHC | GE HealthCare | $86.99 | $93.40 | 7.37% | Buy |
DOCS | Doximity | $41.82 | $39.29 | -6.05% | Buy |
AMWL | American Well | $9.12 | $8.40 | -7.89% | Hold |
SDGR Forecast FAQ
Is Schrödinger a good buy?
Yes, according to 7 Wall Street analysts, Schrödinger (SDGR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 71.43% of SDGR's total ratings.
What is SDGR's price target?
Schrödinger (SDGR) average price target is $28.67 with a range of $27 to $30, implying a 57.18% from its last price of $18.24. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Schrödinger stock go up soon?
According to Wall Street analysts' prediction for SDGR stock, the company can go up by 57.18% (from the last price of $18.24 to the average price target of $28.67), up by 64.47% based on the highest stock price target, and up by 48.03% based on the lowest stock price target.
Can Schrödinger stock reach $30?
SDGR's average twelve months analyst stock price target of $28.67 does not support the claim that Schrödinger can reach $30 in the near future.
What are Schrödinger's analysts' financial forecasts?
Schrödinger's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $207.5M (high $212.22M, low $202.09M), average EBITDA is $-170M (high $-157M, low $-183M), average net income is $-173M (high $-128M, low $-218M), average SG&A $138.2M (high $148.58M, low $127.4M), and average EPS is $-2.51 (high $-2.004, low $-3.002). SDGR's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $245.95M (high $245.95M, low $245.95M), average EBITDA is $-186M (high $-186M, low $-186M), average net income is $-204M (high $-204M, low $-204M), average SG&A $149.57M (high $149.57M, low $149.57M), and average EPS is $-2.807 (high $-2.807, low $-2.807).
Did the SDGR's actual financial results beat the analysts' financial forecasts?
Based on Schrödinger's last annual report (Dec 2022), the company's revenue was $180.96M, beating the average analysts forecast of $148.32M by 22.00%. Apple's EBITDA was $-145M, beating the average prediction of $-117M by 24.09%. The company's net income was $-149M, missing the average estimation of $-153M by -2.36%. Apple's SG&A was $121.47M, beating the average forecast of $94.78M by 28.16%. Lastly, the company's EPS was $-2.1, missing the average prediction of $-2.144 by -2.03%. In terms of the last quarterly report (Sep 2023), Schrödinger's revenue was $42.57M, beating the average analysts' forecast of $37.85M by 12.47%. The company's EBITDA was $-56.193M, beating the average prediction of $-28.618M by 96.36%. Schrödinger's net income was $-62.024M, beating the average estimation of $-49.966M by 24.13%. The company's SG&A was $33M, beating the average forecast of $23.02M by 43.36%. Lastly, the company's EPS was $-0.86, beating the average prediction of $-0.687 by 25.15%